COVID-19 Vaccine Response and Evaluation (CARE) programme" is funded by the Hong Kong Government to monitor the safety of COVID-19 vaccine. Our team at the Department of Pharmacology and Pharmacy of the University of Hong Kong are responsible for conducting the pharmacovigilance on COVID-19 vaccines on behalf of the Department of Health (DH) of Hong Kong SAR Government.
CARE programme applies big data analytics to monitor the safety of COVID-19 vaccine. In this talk, I will firstly describe the healthcare system in Hong Kong. I will also describe how our team work with Hospital Authority and DH to harness the power of electronic medical records to develop a comprehensive pharmacovigilance system. I will then demonstrate the application of big data analytics to conduct pharmacovigilance study to investigate carditis following BNT162b2 vaccination in children [1-3] .
The results of these studies have been used by the DH to support their policy development in vaccination programme. The results have also been widely disseminated in scientific journals and mass media.
